NO993758D0 - Nye forbindelser og mikroorganismer med ökt produksjon av klavulansyre - Google Patents

Nye forbindelser og mikroorganismer med ökt produksjon av klavulansyre

Info

Publication number
NO993758D0
NO993758D0 NO993758A NO993758A NO993758D0 NO 993758 D0 NO993758 D0 NO 993758D0 NO 993758 A NO993758 A NO 993758A NO 993758 A NO993758 A NO 993758A NO 993758 D0 NO993758 D0 NO 993758D0
Authority
NO
Norway
Prior art keywords
microorganisms
new compounds
increased production
clavulanic acid
clavulanic
Prior art date
Application number
NO993758A
Other languages
English (en)
Norwegian (no)
Other versions
NO993758L (no
Inventor
Barry Barton
John Patrick Griffin
Cecilia Anders
Susan Jensen
Roy Henry Mosher
Ashis Sudhakar Paradkar
Original Assignee
Smithkline Beecham Plc
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Univ Alberta filed Critical Smithkline Beecham Plc
Publication of NO993758D0 publication Critical patent/NO993758D0/no
Publication of NO993758L publication Critical patent/NO993758L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO993758A 1997-02-04 1999-08-03 Nye forbindelser og mikroorganismer med ökt produksjon av klavulansyre NO993758L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9702218.0A GB9702218D0 (en) 1997-02-04 1997-02-04 Novel product
PCT/EP1998/000644 WO1998033896A2 (en) 1997-02-04 1998-02-02 Microorganisms with increased production of clavulanic acid

Publications (2)

Publication Number Publication Date
NO993758D0 true NO993758D0 (no) 1999-08-03
NO993758L NO993758L (no) 1999-08-03

Family

ID=10807030

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993758A NO993758L (no) 1997-02-04 1999-08-03 Nye forbindelser og mikroorganismer med ökt produksjon av klavulansyre

Country Status (32)

Country Link
US (5) US6936458B1 (hu)
EP (2) EP0970198B1 (hu)
JP (2) JP4227199B2 (hu)
KR (2) KR100514964B1 (hu)
CN (2) CN1192107C (hu)
AP (1) AP1320A (hu)
AR (2) AR011100A1 (hu)
AT (1) ATE312926T1 (hu)
AU (1) AU735782B2 (hu)
BG (1) BG103704A (hu)
BR (1) BR9807144A (hu)
CA (1) CA2279207A1 (hu)
DE (1) DE69832783T2 (hu)
DZ (1) DZ2413A1 (hu)
EA (1) EA003773B1 (hu)
ES (1) ES2255149T3 (hu)
GB (1) GB9702218D0 (hu)
HU (1) HUP0001048A3 (hu)
ID (1) ID22144A (hu)
IL (1) IL131043A0 (hu)
MA (1) MA24464A1 (hu)
MY (1) MY140928A (hu)
NO (1) NO993758L (hu)
NZ (1) NZ336894A (hu)
OA (1) OA11082A (hu)
PL (1) PL334961A1 (hu)
SK (1) SK105499A3 (hu)
TR (1) TR199901862T2 (hu)
TW (2) TW589377B (hu)
UY (2) UY24874A1 (hu)
WO (1) WO1998033896A2 (hu)
ZA (1) ZA98868B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019959A1 (en) * 1999-09-16 2001-03-22 The Johns Hopkins University Improvement of clavulanic acid production
AU1385701A (en) * 1999-10-22 2001-05-08 Smithkline Beecham Plc Novel compounds
GB0308696D0 (en) * 2003-04-15 2003-05-21 Glaxo Group Ltd New process
EP2589663A1 (en) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Process for production of clavulanic acid
CN107964522B (zh) * 2018-01-04 2020-12-08 上海交通大学 海洋链霉菌dut11及其抗补体活性应用
KR20220031043A (ko) 2019-07-05 2022-03-11 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 스트렙토미세스 클라불리게루스

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
YU40452B (en) * 1975-02-07 1986-02-28 Beecham Group Plc Process for the elimination of contaminating impurities from clavulinic acid
GB1585661A (en) 1976-06-08 1981-03-11 Glaxo Lab Ltd Clavam derivatives
JPS589679B2 (ja) 1977-02-24 1983-02-22 武田薬品工業株式会社 抗生物質の製造法
US4202819A (en) 1979-05-04 1980-05-13 Hoffman-La Roche Inc. 2-(3-Alanyl)clavam antibiotic
GB8521516D0 (en) * 1985-08-29 1985-10-02 Beecham Group Plc Compounds
GB9020683D0 (en) 1990-09-22 1990-11-07 Univ Strathclyde Isolation of dna
CA2108113C (en) * 1993-10-08 2006-12-05 Susan E. Jensen Dna sequence encoding enzymes of clavulanic acid biosynthesis

Also Published As

Publication number Publication date
KR20000070723A (ko) 2000-11-25
US20030124690A1 (en) 2003-07-03
EP0970198B1 (en) 2005-12-14
TW589377B (en) 2004-06-01
US20030022321A1 (en) 2003-01-30
EA199900718A1 (ru) 2000-02-28
BG103704A (en) 2000-05-31
ATE312926T1 (de) 2005-12-15
DE69832783D1 (de) 2006-01-19
CN1696301A (zh) 2005-11-16
AP1320A (en) 2004-10-29
AR011100A1 (es) 2000-08-02
US7344869B2 (en) 2008-03-18
JP4227199B2 (ja) 2009-02-18
CA2279207A1 (en) 1998-08-06
IL131043A0 (en) 2001-01-28
OA11082A (en) 2003-03-13
ID22144A (id) 1999-09-09
UY24874A1 (es) 2001-07-31
WO1998033896A2 (en) 1998-08-06
KR100514964B1 (ko) 2005-09-15
CN1192107C (zh) 2005-03-09
MA24464A1 (fr) 1998-10-01
AP9901614A0 (en) 1999-09-30
SK105499A3 (en) 2000-05-16
EP0970198A2 (en) 2000-01-12
JP2001511001A (ja) 2001-08-07
US6936458B1 (en) 2005-08-30
TR199901862T2 (xx) 2000-12-21
US20030166175A1 (en) 2003-09-04
AR018304A2 (es) 2001-11-14
UY25197A1 (es) 1998-11-27
EP1405913A3 (en) 2004-08-04
DZ2413A1 (fr) 2003-01-04
DE69832783T2 (de) 2006-07-20
TW200307041A (en) 2003-12-01
US20070298470A1 (en) 2007-12-27
EA003773B1 (ru) 2003-08-28
ZA98868B (en) 1999-08-03
CN1251612A (zh) 2000-04-26
NZ336894A (en) 2001-08-31
MY140928A (en) 2010-02-12
JP2009022298A (ja) 2009-02-05
NO993758L (no) 1999-08-03
JP5042186B2 (ja) 2012-10-03
BR9807144A (pt) 2000-01-25
GB9702218D0 (en) 1997-03-26
HUP0001048A3 (en) 2001-09-28
WO1998033896A3 (en) 1998-11-19
EP1405913A2 (en) 2004-04-07
ES2255149T3 (es) 2006-06-16
KR20050053794A (ko) 2005-06-08
HUP0001048A2 (hu) 2000-08-28
AU6295398A (en) 1998-08-25
PL334961A1 (en) 2000-03-27
AU735782B2 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
NO960552D0 (no) Elektrode og fremstilling av elektroden
DE69629670D1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
FI951439A0 (fi) Mikro-organismit tryptofaanin tuottamista varten ja näiden valmistusmenetelmät
NO20015547L (no) Fremgangsmåte for hemisyntese av forbindelser og nye forbindelser
HUP0202705A3 (en) Methods and microorganisms or production of panto-compounds
DE69431408D1 (de) Herstellung von polysuccinimid und polyasparaginsäure
HU9800112D0 (en) Biphenyl-sulfonyl-substituted heterocyclic compounds of fife-membered ring, their production and use
FI940509A0 (fi) Menetelmä normaalin ja ultrahienon sementin valmistamiseksi
DE69737044D1 (de) Herstellung von fugizides Chinazolinonen und nützliche Zwischenprodukte
PL329241A1 (en) Novel derivatives of alpha-hydroxycarboxylic acids, their production and application
NO991382D0 (no) Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin
DE59606486D1 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
PL329240A1 (en) Novel derivatives of carboxylic acid, their production and application
DE69816274D1 (de) Herstellung von carbonsäureverbindungen und deren derivaten
NO993758L (no) Nye forbindelser og mikroorganismer med ökt produksjon av klavulansyre
NO994505L (no) Forbedret fremgangsmåte for fremstilling av tiazolidindioner og nye tiazolidindioner
PL311257A1 (en) New compounds and method of their production as well as pharmaceutical compounds and method of its production
HUP9800343A3 (en) Process for the production of clavulanic acid and/or salts thereof
EE9700186A (et) Klavulaanhappe soolad
NO941073D0 (no) Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater
PL325398A1 (en) Novel derivatives of carboxylic acids, their production and application
NO942598D0 (no) Miniatyr bioreaktor med kontinuerlig fornyelse av næringsmedium
NO961808D0 (no) Konstruksjon og produksjon av vaksine
DE59606492D1 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
NO972960L (no) E.coli-mutant med redusert produksjon av organisk syre

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application